Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) Asset Utilization Ratio (2016 - 2025)

Dare Bioscience's Asset Utilization Ratio history spans 9 years, with the latest figure at 0.03 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 6588.35% year-over-year to 0.03; the TTM value through Dec 2025 reached 0.03, up 6588.35%, while the annual FY2025 figure was 0.04, 8270.01% up from the prior year.
  • Asset Utilization Ratio reached 0.03 in Q4 2025 per DARE's latest filing, up from 0.0 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.27 in Q1 2023 to a low of 0.0 in Q3 2025.
  • Average Asset Utilization Ratio over 4 years is 0.11, with a median of 0.11 recorded in 2023.
  • The largest YoY upside for Asset Utilization Ratio was 6588.35% in 2025 against a maximum downside of 102.89% in 2025.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.21 in 2022, then plummeted by 42.91% to 0.12 in 2023, then tumbled by 99.6% to 0.0 in 2024, then surged by 6588.35% to 0.03 in 2025.
  • Per Business Quant, the three most recent readings for DARE's Asset Utilization Ratio are 0.03 (Q4 2025), 0.0 (Q3 2025), and 0.0 (Q2 2025).